ProQR Therapeutics (PRQR) Assets Average (2014 - 2023)

ProQR Therapeutics' Assets Average history runs 9 years deep, the most recent figure standing at $151.5 million for Q4 2023.

• In Q4 2023, Assets Average rose 1.83% year-over-year to $151.5 million; the TTM figure through Dec 2023 stood at $151.5 million (up 1.83% YoY), while the FY2025 annual figure was $155.4 million, down 5.22% from the prior year.
• Assets Average came in at $151.5 million for Q4 2023 at ProQR Therapeutics, down from $157.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $57753.9 billion in Q1 2019 to a low of $95.8 million in Q3 2019.
• A 5-year average of $5781.0 billion and a median of $161.6 million in 2023 frame the typical range for Assets Average.
• On a YoY basis, Assets Average climbed as much as 222153.36% in 2019 and fell as far as 100.0% in 2019.
• ProQR Therapeutics' Assets Average stood at $110.2 million in 2019, then rose by 11.86% to $123.2 million in 2020, then jumped by 90.77% to $235.1 million in 2021, then slumped by 36.71% to $148.8 million in 2022, then climbed by 1.83% to $151.5 million in 2023.
• According to Business Quant data, Assets Average over the past three periods registered $151.5 million, $157.9 million, and $165.4 million for Q4 2023, Q3 2023, and Q2 2023 respectively.

Peer Comparison